The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 16, 2018
Filed:
May. 22, 2018
Applicant:
Shanghai Yingli Pharmaceutical Co., Ltd., Shanghai, CN;
Inventors:
Zusheng Xu, Shanghai, CN;
Nong Zhang, Shanghai, CN;
Qingrui Sun, Shanghai, CN;
Tianzhi Wu, Shanghai, CN;
Assignee:
SHANGHAI YINGLI PHARMACEUTICAL CO., LTD., Shanghai, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 217/14 (2006.01); C07D 231/56 (2006.01); C07D 237/30 (2006.01); C07D 333/60 (2006.01); C07D 495/04 (2006.01); C07D 471/04 (2006.01); C07D 239/78 (2006.01); C07D 405/04 (2006.01); C07B 59/00 (2006.01);
U.S. Cl.
CPC ...
C07D 217/14 (2013.01); C07B 59/002 (2013.01); C07D 231/56 (2013.01); C07D 237/30 (2013.01); C07D 239/78 (2013.01); C07D 333/60 (2013.01); C07D 405/04 (2013.01); C07D 471/04 (2013.01); C07D 495/04 (2013.01); C07B 2200/05 (2013.01);
Abstract
Disclosed are a condensed ring derivative, and a preparation method, an intermediate, a pharmaceutical composition and a use thereof. The condensed ring derivative of the present invention has a significant inhibitive effect on URAT1, which can effectively alleviate or treat hyperuricemia and other related diseases.